NCT03367390View on ClinicalTrials.gov

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 8, 2017

Primary Completion Date

February 9, 2018

Study Completion Date

February 9, 2018

Conditions
Type1 Diabetes Mellitus
Interventions
DEVICE

AID System

AID system

DRUG

Insulin Lispro

Individualized doses of insulin lispro administered via the AID system to maintain glycemic control, except during procedures designed to induce hyperglycemia and hypoglycemia.

Trial Locations (1)

98057

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Renton

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03367390 - A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) | Biotech Hunter | Biotech Hunter